Bristol-Myers Squibb
BMY
#196
Rank
C$158.74 B
Marketcap
C$77.74
Share price
0.67%
Change (1 day)
27.92%
Change (1 year)

Revenue for Bristol-Myers Squibb (BMY)

Revenue in 2026 (TTM): C$66.80 Billion

According to Bristol-Myers Squibb's latest financial reports the company's current revenue (TTM ) is C$66.39 Billion. In 2025 the company made a revenue of C$66.00 Billion a decrease over the revenue in the year 2024 that were of C$69.30 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bristol-Myers Squibb from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) C$66.80 B1.22%
2025 C$66.00 B-4.77%
2024 C$69.30 B16.11%
2023 C$59.69 B-4.7%
2022 C$62.63 B5.96%
2021 C$59.11 B9.04%
2020 C$54.21 B58.77%
2019 C$34.14 B11.11%
2018 C$30.73 B17.66%
2017 C$26.12 B0.05%
2016 C$26.10 B13.65%
2015 C$22.97 B24.66%
2014 C$18.42 B5.65%
2013 C$17.44 B-0.46%
2012 C$17.52 B-18.91%
2011 C$21.60 B10.95%
2010 C$19.47 B10.86%
2009 C$17.56 B-29.85%
2008 C$25.04 B37.31%
2007 C$18.23 B-12.55%
2006 C$20.85 B-6.73%
2005 C$22.36 B5.99%
2004 C$21.09 B-22.64%
2003 C$27.27 B-4.7%
2002 C$28.61 B-6.34%
2001 C$30.55 B6.93%
2000 C$28.57 B2.27%
1999 C$27.94 B-0.61%
1998 C$28.11 B17.81%
1997 C$23.86 B15.64%
1996 C$20.63 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
C$131.95 B 98.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$77.47 B 16.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$86.69 B 30.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$83.74 B 26.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$98.93 B 49.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$50.96 B-23.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$75.94 B 14.39%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$13.60 B-79.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$90.05 B 35.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$82.76 B 24.66%๐Ÿ‡ฌ๐Ÿ‡ง UK